Skip to main content

Table 3 FINNAKI cohort. Laboratory analyses

From: The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery

 

ALL [N = 306]

NO-AKI [N = 238 (77.8%)]

AKI [N = 68 (22.2%)]

Pre-operative creatinine (μmol/L)

84 (72–97)

84 (72–94)

92 (75–109)**

Pre-operative NGAL (ng/ml)

21.5 (17.8–28.1)

21.0 (17.2–26.8)

22.6 (20.0–31.7)*

Pre-operative LF (ng/ml)

117 (72–189)

116 (72–192)

119 (70–167)

Pre-operative WBC count (10E9)

6.8 (5.7–8.2)

6.7 (5.6–8.1)

7.2 (6.2–9.1)*

NGAL at admission to ICU (ng/ml)

39.0 (28.6–52.6)

37.9 (27.3–48.7)

48.8 (35.4–61.7)***

LF at admission to ICU (ng/ml)

489 (338–651)

471 (336–622)

538 (362–856)*

WBC count at 1st postoperative day (10E9)

9.5 (7.9–12.1)

9.2 (7.8–11.8)

10.8 (8.2–13.0)*

  1. Data are median (interquartile range) or number (percentage). WBC - white blood cell count
  2. *p < 0.05, **p < 0.01, ***p < 0.001 for AKI vs NO-AKI. NGAL neutrophil gelatinase-associated lipocalin, LF lactoferrin, WBC white blood cell, ICU intensice care unit